Plasma Resilience: Europe's Lifeline
Medicines made from human plasma are essential for developing therapies for various conditions, including rare inherited disorders and immunodeficiencies.
Human plasma, accounting for 55% of our blood, is a protein-rich liquid that cannot be produced in a lab, relying on donations from real people.
- Over 12 million people in Europe donate plasma annually.
- Donations are governed by EU Member States, International Quality Plasma Program (IQPP), and the Plasma Protein Therapeutics Association (PPTA).
Despite this, nearly 40% of plasma used for European medicines is imported from the United States, highlighting the vulnerability of Europe's supply chain.
Europe's supply chain of this valuable resource is extremely vulnerable.
Author's summary: Europe relies heavily on plasma donations.
More News
- From Rails to Trails
- Who knew that the public would end up supporting striking teachers? Not Danielle Smith and the UCP! - Alberta Politics
- Wilson is wrong about women’s rights and the 19th Amendment
- Electric Island Expands with Five Shows and a Massive Lineup
- Marshalltown Ansons team made city a ‘Baseball Town’
- Solomon Named Big South Preseason Player of the Year; Bulldogs Picked Second in Preseason
- Mateusz Gamrot Releases His First Statement Following His Loss To Charles Oliveira
- Who won fashion month SS26 on social media?